Breaking
🌏 NMPA
Sun Pharma Organon Partnership to Expand Access to Key Medicines
Newswomen's health, spasticity, rheumatoid arthritisMay 4, 2026

Sun Pharma Organon Partnership to Expand Access to Key Medicines

Sun Pharma has announced a strategic partnership with Organon to commercialize five of Organon's established products across India. This collaboration aims to leverage Sun Pharma's extensive network to improve patient access to vital treatments.

Dr. Yuna Park
Purdue Pharma Shutdown: $7.4B Deal Ends OxyContin Maker's Era
AnalysisPainMay 2, 2026

Purdue Pharma Shutdown: $7.4B Deal Ends OxyContin Maker's Era

Purdue Pharma, the manufacturer of OxyContin, is ceasing operations as part of a $7.4 billion settlement to resolve claims related to the opioid crisis. This landmark deal signifies a major turning point in the legal and societal reckoning with the epidemic.

Dr. Yuki Tanaka